Headlands Technologies’s AdaptHealth AHCO Stock Holding History

Headlands Technologies’s Portfolio AHCO Stock Details AHCO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-885	Closed	-$8.05K	–	935
2023 Q3	$8.05K	Buy	+885	New	+$10.6K	﹤0.01%	717

Other funds holding AHCO

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

OCA

OEP Capital Advisors New York $194M AUM 9.78% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

SkyKnight Capital San Francisco, California $107M AUM 9.69% 1-Year Est. Return

Reinhart Partners Mequon, Wisconsin $4.38B AUM 55.55% 1-Year Est. Return

Truist Financial Charlotte, North Carolina $74.2B AUM 21.09% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

SBH

Segall Bryant & Hamill Chicago, Illinois $6.98B AUM 34.78% 1-Year Est. Return

Headlands Technologies's AHCO Position: Q4 2023 in Review

Headlands Technologies sold out of AdaptHealth (AHCO) in Q4 2023, closing a stake of 885 shares — an estimated $8.05K sold.

Headlands Technologies first reported a position in AHCO in Q3 2023 and held it in 1 quarter. The position peaked at $8.05K in Q3 2023. 192 funds tracked by Wall St. Rank hold AHCO as of Q4 2023.

Headlands Technologies reported no remaining AdaptHealth position as of Q4 2023 after selling out during the quarter.
Headlands Technologies sold 885 AdaptHealth shares in Q4 2023, an estimated $8.05K.
Headlands Technologies first reported a position in AdaptHealth in Q3 2023 and held it in 1 quarter.
Headlands Technologies's AdaptHealth position peaked at $8.05K in Q3 2023.
192 funds tracked by Wall St. Rank held AdaptHealth as of Q4 2023.

Based on Headlands Technologies's 13F filing for Q4 2023, filed 2 Feb 2024.